Moreover, since CDC6 consistently yielded positive results in previous proliferation and migration assays, it suggests that CDC6 is a key downstream factor in the promotion of pancreatic cancer progression by the PVT1-MYC duet. The gene discussed is PVT1; the disease is familial pancreatic carcinoma.